Clinical Trial Update: IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition [NA]

View source ↗

Summary

This clinical trial evaluates accelerated transcranial magnetic stimulation for depression with comorbid post-COVID-19 condition, focusing on immune and psychom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Max-Planck-Institute of Psychiatry | Conditions: Depressive Disorder, Post-Acute COVID-19 Syndrome | NA | Status: RECRUITING